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the   microenvironment. Two major factors enable microglia to be 
maintained in the resting state. The ﬁ  rst is the global absence of 
positive soluble stimulatory factors like interferon-γ (IFNγ) which 
is present in signiﬁ  cant concentrations only in times of stress or 
injury (Neumann, 2001). The second is the maintenance of cell-
cell interactions via ligand-receptor expression and binding, for 
example interaction between CD200 which is expressed on neu-
rons and CD200 receptor, which is expressed on microglia (Hoek 
et al., 2000).
When stimulated, microglia undergo a morphological and func-
tional transformation. There is a growing recognition that several 
subtypes of activated microglia exist (Perry et al., 2007; Lynch, 
2009) but it is probably reasonable to broadly categorize activated 
microglia functionally into cells involved in antigen presentation, 
cells which variously release neurotrophins, chemokines, cytokines 
and reactive oxygen and nitrogen species, and cells which perform 
phagocytic functions. At this point, it is not possible to determine 
precisely how many intermediate states exist, nor to be conﬁ  dent 
that any or all of these states can co-exist. However what has become 
clear is that features of activated microglia have been identiﬁ  ed in 
the brain of aged individuals while they are also characteristic of 
several neurodegenerative diseases and evident in brains of both 
aged animals (Lynch et al., 2007; Lyons et al., 2007a) and animal 
models of neurodegenerative diseases (McGeer and McGeer, 1998; 
Chen et al., 2005).
WHAT INFLAMMATORY CHANGES HAVE BEEN IDENTIFIED IN 
THE AGED BRAIN?
EVIDENCE OF GLIAL ACTIVATION
Microarray analysis of brain tissue prepared from young and aged 
rodents has demonstrated that of the genes which are upregulated 
with age, about half are associated with inﬂ  ammation and oxidative 
INTRODUCTION
The brain has many unique immunological properties but it is not 
an immunologically-isolated organ (Akiyama et al., 2000). It differs 
from the periphery in that it is devoid of a lymphatic system to 
capture potential antigen, and expression of major histocompat-
ability complexes I and II is very low in the normal brain indicating 
the lack of a professional antigen presentation system. A further 
specialization is that the entry of inﬁ  ltrating cells, as well as larger 
molecules, are largely excluded by the blood brain barrier under 
normal conditions. However research in the past decade or two 
has led to the realization that the brain is exquisitely sensitive to 
inﬂ  ammatory molecules and that the balance between pro- and 
anti-inﬂ  ammatory inﬂ  uences in the microenvironment profoundly 
affects neuronal function.
It is now clear that neuroinﬂ  ammation is a characteristic of 
many neurodegenerative disorders including Alzheimer’s Disease 
(AD) and some authors, but by no means all, believe that chronic 
neuroinﬂ  ammation may be an initiator in the cascade of events 
leading to the deﬁ  cit in neuronal function which deﬁ  nes the disease. 
However even in the healthy brain, neuroinﬂ  ammatory changes 
become evident as the individual ages and with the increase in 
the ageing population and the age-dependency of neurodegen-
erative disorders, there is a signiﬁ  cant impetus to gain a greater 
understanding of the causes and consequences of the inﬂ  ammatory 
changes that occur in the brain.
MICROGLIA – THE IMMUNE CELLS OF THE BRAIN
Microglia are the principal immune cells of the brain. Like mac-
rophages, they are derived from bone marrow stem cells but 
become trapped in the CNS during early development. Under 
normal conditions, these cells adopt a ramiﬁ  ed appearance and 
are in a so-called ‘resting state’; their main role is surveillance of 
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stress (Prolla, 2002). In another study, upregulation of both MHCII 
and glial ﬁ  brillary acidic protein (GFAP) was reported in the brain 
of aged mice supporting the view that activation of microglia and 
astrocytes respectively are features of ageing (Godbout et al., 2005) 
and these ﬁ  ndings are supported by evidence from immunohis-
tochemical analysis and analysis of age-related changes in MHCII 
and GFAP mRNA (Lyons et al., 2009a).
MHCII interacts with T cell receptor provided costimulators 
CD80 and/or CD86 are also expressed on antigen-presenting cells 
like microglia, and it turns out that CD86 is increased in the hip-
pocampus of aged rats accompanying the increase in MHCII and 
intercellular cell adhesion molecule (ICAM) expression (Grifﬁ  n 
et al., 2006; Downer et al., 2010). Therefore it must be anticipated 
that, with age, increased interaction between T cells and microglia 
is likely to occur. With respect to the presence of T cells in the brain, 
it is widely accepted that cell numbers are low in the healthy brain, 
but that they increase dramatically in response to an immunological 
challenge (Hickey, 2001; Bailey et al., 2006). Passage of T cells into 
the brain is facilitated by the chemokine monocyte chemotactic 
protein-1 (MCP-1) acting in cooperation with another chemokine, 
macrophage inﬂ  ammatory protein-1 (MIP-1α) (Aloisi et al., 2000) 
and the evidence shows that these chemokines are increased with 
age (Kumagai et al., 2007) and that there are age-related increases 
in both CD3 + lymphocytes and CD11c + dendritic cells in brain 
(Stichel and Luebbert, 2007).
WHAT ARE THE CONSEQUENCES OF AN INTERACTION BETWEEN 
T CELLS AND MICROGLIA?
In the last decade or so, it has become clear that interaction 
between T cells and microglia impacts on the activation state of 
both cell types. It was shown that T helper 1 (Th1) cells induced 
expression of MHCII, CD40, and CD54 on the surface of micro-
glia, whereas Th2 cells failed to induce signiﬁ  cant upregulation of 
these molecules (Aloisi et al., 1998, 2000). Th1 cells have also been 
shown to increase expression of CD80 on microglia (Wolf et al., 
2001). On the other hand, microglia isolated from the CNS of mice 
were shown to induce production of IFNγ and IL-2 by Th1 cells, 
while IFNγ, in turn, upregulated expression of MHCII, CD40, and 
CD54 (Aloisi et al., 2000). In addition to the age-related increase in 
expression of MHCII, CD80 and CD86, activated microglia express 
CD40, CD11b and molecules such as ICAM (Grifﬁ  n et al., 2006; 
Lyons et al., 2009a) and binding of CD40 to its ligand, CD154, 
which is expressed primarily on activated T cells (Townsend et al., 
2005) is also important in the interaction between microglia and 
T cells.
Recent work in this laboratory aimed to further investigate the 
consequences of interaction between microglia and T cells. In this 
case, amyloid-β (Aβ)-speciﬁ  c T cells and myelin oligodendrocyte 
glycoprotein (MOG)-speciﬁ  c T cells were prepared and incubated 
in the presence of microglia prepared from transgenic mice which 
overexpressed amyloid precursor protein (APP) and presenilin-1 
and MOG-treated mice (in which clinical symptoms of experimen-
tal autoimmune encephalomyelitis were demonstrated) respectively. 
The data indicated that Th1 cells markedly increased expression 
of cell surface markers on microglia and also increased produc-
tion of inﬂ  ammatory cytokines (Murphy et al., 2009; McQuillan 
et al., 2009).
These ﬁ  ndings clearly indicate that the presence of Th1 cells in 
the brain exerts a signiﬁ  cant effect on microglial activation and 
could potentially trigger a cascade of events leading to profound 
neuroinﬂ  ammation.
EXPRESSION OF CYTOKINES IS ALTERED 
IN THE BRAIN WITH AGE
Activated microglia are considered to be the primary cell source 
of inﬂ  ammatory cytokines like IL-1β, IL-6 and TNFα, although 
astrocytes, when activated, also release these cytokines, particularly 
IL-6 (Li et al., 2009). The evidence suggests that reactive astrogliosis 
also occurs with age and a number of groups have reported that an 
age-related increase in GFAP (Kohama et al., 1995; Hayakawa et al., 
2007). In parallel with glial activation, increases in these inﬂ  amma-
tory cytokines have been reported in brain tissue obtained from 
aged rats and/or mice (Lynch and Lynch, 2002; Martin et al., 2002; 
Godbout and Johnson, 2004; Gelinas and McLaurin, 2005; Maher 
et al., 2005; Nolan et al., 2005; Campuzano et al., 2009). Age-related 
increases in concentration of other inﬂ  ammatory cytokines have 
also been reported. For example IL-18, which is also released from 
activated microglia, is increased in hippocampal tissue prepared 
from aged, compared with young, rats (Grifﬁ  n et al., 2006) and, 
like IL-1β and IL-6 (Grifﬁ  n, 2006), its expression is increased in 
post-mortem brain tissue prepared from patients with AD (Ojala 
et al., 2009). IFNγ concentration is also increased in the hippoc-
ampus with age but the cell course is unclear (see IFNγ is a potent 
activator of microglia).
In aged rodents, the reported increase in hippocampal concen-
tration of IL-1β is accompanied by a decrease in IL-4 (Maher et al., 
2005; Lynch et al., 2007) and, similarly, the age-related increase in 
IL-6 (Ye and Johnson, 1999) is accompanied by a decrease in release 
of the anti-inﬂ  ammatory cytokine IL-10 from brain slices (Ye and 
Johnson, 2001). While IL-10 suppresses synthesis of proinﬂ  am-
matory cytokines in brain (Strle et al., 2001), IL-4 decreases IL-1β 
mRNA synthesis and IL-1β release from glia (Loane et al., 2007; 
Lynch et al., 2007) and these ﬁ  ndings, together with similar ﬁ  ndings 
of others (Kitamura et al., 2000; Benveniste et al., 2004; Iribarren 
et al., 2005; Zhao et al., 2006), highlight the modulatory effect of 
anti-inﬂ  ammatory cytokines on glial activation. The possibility 
therefore exists that the age-related decrease in concentration of 
anti-inﬂ  ammatory cytokines may be the primary contributory fac-
tor in driving the age-related inﬂ  ammatory phenotype.
WHAT ARE THE CONSEQUENCES OF THESE 
NEUROINFLAMMMATORY CHANGES?
INFLAMMATORY CHANGES PROFOUNDLY AFFECT BEHAVIOUR
One of the important ramiﬁ  cations of an increase in inﬂ  ammatory 
cytokines in the brain is that they profoundly affect behaviour. The 
effect of IL-1β on behaviour is most studied with multiple effects 
documented; it modulates exploratory behaviour, social explora-
tion, social interaction and it also exerts a signiﬁ  cant effect on the 
hypothalamic pituitary axis and therefore impacts on feeding and 
drinking behaviour and on sleep (Goshen and Yirmiya, 2009). It has 
been shown to speciﬁ  cally affect hippocampal-dependent learning. 
The ﬁ  rst reported effect was in 1993 and, in this study, rats injected 
intracerebroventricularly with IL-1β exhibited poor performance in 
the Morris water maze (Oitzl et al., 1993). Further studies supported Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  6 | 3
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(Wang et al., 2004). Further evidence of a negative impact of TNFα 
on LTP was recently obtained from this laboratory by the ﬁ  nding 
that intracerebroventricular injection of TNFα inhibited LTP in 
dentate gyrus while the deﬁ  cit in LTP in aged rats was coupled with 
increased expression of TNFα in hippocampus.
Several experiments have also indicated that intracerebroven-
tricular injection of IL-1β inhibits LTP in perforant path-granule 
cell synapses (Murray and Lynch 1998; Kelly et al., 2003; Nolan 
et al., 2005) while LTP is also attenuated when IL-1β concentration 
in hippocampus is increased by injection of LPS (Lonergan et al., 
2004; Lynch et al., 2004; Barry et al., 2005) or Aβ peptides (Lynch 
et al., 2007; Minogue et al., 2003, 2007). IL-1β concentration is also 
increased in brain tissue of animals following exposure to irradia-
tion and this, too, is associated with decreased LTP (Lonergan et al., 
2002; Lynch et al., 2003).
It is important to note that low concentrations IL-1β and IL-6 
are likely to play a physiological function in LTP maintenance. 
Several studies have demonstrated that full expression of LTP is 
prevented in the absence of IL-1β or IL-6 and, moreover, it has 
been reported that IL-1ra, which acts to prevent the action of 
IL-1β, can block LTP (Schneider et al., 1998; Avital et al., 2003; 
Ross et al., 2003; Balschun et al., 2004).
Deﬁ  cits in LTP in aged rats are associated with 
neuroinﬂ  ammatory changes
Several studies have demonstrated that the ability of aged rats to 
sustain LTP is impaired in some way and, in an excellent review, 
Burke and Barnes exhaustively assessed some of the factors which 
contribute to this; whereas synaptic loss or loss of dendritic branch-
ing is largely unaffected with age, synaptic loss and synaptic restruc-
turing are evident and, together with alterations in calcium handling 
by cells and gene expression, correlate with impairment in certain 
behaviours and in LTP (Burke and Barnes, 2006). However it has 
also been shown that the deﬁ  cit in LTP in dentate gyrus in aged rats 
is positively correlated with IL-4 concentration in the hippocampus 
and inversely correlated with hippocampal IL-1β concentration 
(Maher et al., 2005) and, while increased microglial activation is 
clearly evident in aged rats that fail to sustain LTP, this was not the 
case in aged rats which were capable of sustaining LTP (Maher et al., 
2006). The negative impact of microglial activation on the ability of 
aged rats to sustain LTP is supported by the ﬁ  nding that minocy-
cline, which inhibits microglial activation, at least partially restores 
LTP in aged rats (Grifﬁ  n et al., 2006) and that IL-4, which reduces 
microglial activation, exerts a similar beneﬁ  cial effect (Nolan et al., 
2005). Indeed aged rats which received atorvastatin, rosiglitazone or 
the polyunsaturated fatty acid, eicosapentaenoic acid (EPA), were 
all capable of sustaining LTP compared with untreated aged rats and 
interestingly, the age-related microglial activation was attenuated 
by treatment in each of these cases, providing further evidence of 
a causative link between microglial activation and impaired LTP 
(Lynch et al., 2007; Clarke et al., 2008; Loane et al., 2009).
WHAT SIGNALLING EVENTS ARE TRIGGERED 
BY INFLAMMATORY CYTOKINES?
The functional receptor for IL-1β is IL-1 type 1 receptor (IL-1R1) 
and its importance in driving neuroinﬂ  ammatory changes in the 
brain has been clearly identiﬁ  ed. Brain injury, for example a stab 
this ﬁ  nding with the observations that   hippocampal-dependent 
tasks were also impaired when IL-1β concentration in hippocampus 
was increased following intraperitoneal injection or intrahippoc-
ampal injection of IL-1β (Gibertini et al., 1995; Barrientos et al., 
2002), infection with Legionella Pneumophila (Gibertini et al., 1995) 
or, intracerebroventricular injection of Human Immunodeﬁ  ciency 
Virus-1 envelope glycoprotein gp120 (Pugh et al., 2000). Injection 
of the gram-negative bacterial component lipopolysaccharide 
(LPS), has also been shown to affect spatial learning but, at least 
in the Morris water maze, there is the possible confound of the 
LPS-induced sickness behaviour which presents interpretative dif-
ﬁ  culties (Cunningham and Sanderson, 2008).
An important recent ﬁ  nding was that persistent overexpression 
of IL-1β in rat hippocampus (by activating the dormant human 
IL-1β excisional activation transgene (IL-1βXAT) had a detrimen-
tal effect on hippocampal-dependent learning; both contextual 
fear conditioning and behaviour in the Morris water maze were 
affected (Hein et al., 2009) and the negative impact on behaviour 
was accompanied by evidence of microglial activation, increased 
prostaglandin E2 and IL-1β concentrations and increased expres-
sion of the chemokines MCP-1 and MIP-1 (Moore et al., 2009). 
Interestingly chronic upregulation of IL-6 by astrocytes is also 
associated with a progressive, age-related decline in avoidance 
learning, coupled with evidence of microglial activation (Heyser 
et al., 1997).
Deﬁ  cits in hippocampal-dependent behaviour in aged rats are linked 
with neuroinﬂ  ammatory changes
Many studies have demonstrated that spatial learning is decreased 
with age (Rapp and Gallagher, 1996; Rosenzweig and Barnes, 2003; 
Driscoll et al., 2006) and these changes have been linked with sev-
eral age-related changes in hippocampal physiology, morphology 
and signalling. Recently it has been suggested that the age-related 
deﬁ  cit in hippocampal-dependent learning is, at least in part, due 
to the age-related increase in IL-1β (Gemma and Bickford, 2007) 
and recent data from this laboratory has shown that the deﬁ  cit in 
performance in the Morris water maze in aged rats, accompanied 
by a decrease in long-term potentiation (LTP), was associated with 
evidence of inﬂ  ammation characterized by microglial activation.
INFLAMMATORY CYTOKINES, WHICH ARE INCREASED WITH AGE, 
NEGATIVELY AFFECT LTP
These data highlight the negative impact that inﬂ  ammatory 
cytokines exert on synaptic plasticity and are mirrored by several 
reports of an inhibitory effect on LTP in vitro and in vivo. In vitro 
analysis has revealed that application of IL-1β inhibits LTP in CA1 
(Bellinger et al., 1993; Ross et al., 2003), CA3 (Katsuki et al., 1990) 
and also in dentate gyrus (Cunningham et al., 1996). IL-18 has been 
classiﬁ  ed as a member of the IL-1 family and, signiﬁ  cantly, like IL-
1β, IL-18 inhibits LTP; interestingly the effects of both IL-1β and 
IL-18 on LTP are inhibited by the endogenous IL-1 receptor antago-
nist, IL-1ra (Curran and O’Connor, 2001; Loscher et al., 2003). 
Both TNFα and IL-6 have also been shown to inhibit LTP in vitro 
(Bellinger et al., 1995; Tancredi et al., 2000; Curran and O’Connor, 
2003); indeed the inhibitory effect of Aβ on LTP is reported to 
be TNFα-mediated since slices prepared from mice deﬁ  cient in 
TNFα were capable of sustaining LTP even in the presence of Aβ Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  6 | 4
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We have also shown that implantation of IL-1β-containing pel-
lets which deliver the cytokine over a 4-week period, exerts a more 
profound inhibitory effect on LTP in dentate gyrus of 9-month old, 
compared with 3-month-old rats. Similarly, intracerebroventricular 
injection of Aβ1-42 (20 µM), which was found to exert no substantial 
effect on expression of LTP in young rats, markedly decreased it 
in aged rats and this was accompanied by a more profound effect 
on IL-1β concentration in hippocampus of aged rats (Minogue 
et al., 2007).
WHAT IS RESPONSIBLE FOR THE NEUROINFLAMMATORY 
CHANGES WHICH ACCOMPANY AGEING?
While there is compelling evidence that microglial activation occurs 
with age, the factors which contribute to this change need to be 
clariﬁ  ed. A good starting point for consideration of this issue is 
the knowledge that in the intact healthy brain, the maintenance 
of microglia in their resting state is determined by the absence of 
stimulatory factors like IFNγ and reduced interaction of microglia 
with other cells like neurons.
IFNγ   IS A POTENT ACTIVATOR OF MICROGLIA
IFNγ is known to be one of the most potent activators of microglia 
(Benveniste et al., 2004) and, predictably, its expression is increased 
in the brain of aged animals (Maher et al., 2006; Moore et al., 2007; 
Clarke et al., 2008). Increased expression has also been reported in 
the brain of older wild-type (Wei et al., 2000) and Tg2575 (Abbas 
et al., 2002) mice, and in Aβ-treated rats in which microglia also 
adopt an activated phenotype (Minogue et al., 2007). The cell source 
of IFNγ in the brain is not clear and we have been unable to show 
that it is released from microglia, although one group reported 
that IFNγ-immunoreactive CD11b-positive cells were observed in 
brain of severe combined immune-deﬁ  cient mice following infec-
tion with Toxoplasma gondii (Suzuki et al., 2005). In the periphery, 
the primary cell source of is generally considered to be NK cells 
(Murasko and Jiang, 2005), although it is also released from Th1 
cells, and recent evidence from this laboratory has identiﬁ  ed the 
presence of NK cells in the brain, with an increase in cell number 
with age (Murphy and Lynch, 2009).
INTERACTION OF MICROGLIA WITH OTHER CELLS 
AFFECTS ACTIVATION STATE
Microglia interact with other cells which inﬂ  uence their activation 
state and reference has already been made to their interaction with 
T cells (see What are the consequences of an interaction between T 
cells and microglia?). However it has become clear in the past few 
years that they also interact with neurons with at least 2 pairs of 
ligands and receptors, fractalkine (also known as CX3CL1) and its 
receptor, and CD200 and CD200 receptor, playing a part in main-
tenance of microglia in a quiescent state. Fractalkine is localized 
principally on neurons (Harrison et al., 1998) (Maciejewski-Lenoir 
et al., 1999), while the receptor is expressed chieﬂ  y on microglial 
cells (Harrison et al., 1998) and it has been shown that addition 
of soluble fractalkine, or neurons on which membrane-associated 
fractalkine is expressed, to LPS-stimulated microglia, markedly 
reduce their activation (Lyons et al., 2009a). Fractalkine expres-
sion is decreased with age and this is functionally associated with 
an increase in microglial activation and a decrease in the ability of 
wound, induces profound microglial activation, inﬁ  ltration of 
macrophages to the site of injury, and increased proinﬂ  amma-
tory cytokine production but these responses are all decreased in 
IL-1R1-null mice (Basu et al., 2002) and the neuroinﬂ  ammatory 
changes induced by hypoxic injury were similarly reduced in these 
mice (Basu et al., 2005). Activation of IL-1R1 leads to a myriad 
of responses; the ﬁ  rst step involves protein:protein interactions 
and formation of a complex which includes adaptor proteins like 
MyD88, and the subsequent activation of IRAK. Further down-
stream, a complex which includes TRAF6 is formed triggering a 
sequence of steps that include phosphorylation of JNK and p38 and 
activation of transcription factors which include NFκB and c-jun. 
In the brain of aged rats, the reported increase in IL-1β is coupled 
with increased expression of IL-1R1 and with increased activation 
of IRAK1, JNK and p38 (Lynch and Lynch, 2002).
Understanding the mechanism by which IL-1β inhibits LTP has 
been approached by analysis of the effect of IL-1β on signalling 
events and by assessment of the modulatory effects of inhibitors. 
IL-1β, and triggers like LPS and Aβ which increase IL-1β, have 
been shown to increase activation of JNK (Vereker et al., 2000a,b; 
Minogue et al., 2003) and, consistent with this, intracerebroven-
tricular injection of the JNK inhibitor, D-JNKI1, ameliorates the 
inhibition of LTP induced by IL-1β, LPS and Aβ (Minogue et al., 
2003; Barry et al., 2005) or amyloid-β (Aβ) peptides (Minogue et al., 
2003, 2007; Lynch et al., 2007). Similarly, application of the JNK 
inhibitor, SP600125, to slices blocked the IL-1β-induced inhibition 
of LTP (Curran et al., 2003). A role for p38 has also been identi-
ﬁ  ed; thus IL-1β and LPS increase p38 activation and decrease LTP 
(Vereker et al., 2000b; Kelly et al., 2003), while treatment of rats with 
the p38 inhibitor, SB203580, attenuated the LPS-induced inhibition 
of LTP (Kelly et al., 2003). p38 activation has also been implicated 
in the inhibitory effect of TNFα on the early phase of LTP (Butler 
et al., 2004).
Although it simply provides circumstantial evidence, it has been 
shown that age-related activation of JNK and p38, which accom-
panies the deﬁ  cit in LTP, are decreased in tissue prepared from 
aged rats treated with EPA (Martin et al., 2002). Similarly, when 
IL-1β- or LPS-induced inhibition of LTP is attenuated by EPA, or 
the anti-inﬂ  ammatory cytokines IL-4 or IL-10, or atorvastatin, then 
activation of the kinases, and indeed NFκB and c-jun, is reduced 
(Kelly et al., 2001; Lonergan et al., 2004; Lynch et al., 2004; Barry 
et al., 2005; Nolan et al., 2005; Clarke et al., 2008).
THE AGE-RELATED NEUROINFLAMMATION SENSITIZES THE 
BRAIN TO INFLAMMATORY STIMULI
Pre-existing underlying inﬂ  ammation increases the vulnerability 
of aged rats to stressors. This has been consistently demonstrated 
in terms of responsiveness to LPS where exacerbation of micro-
glial activation (particularly in terms of IL-1β-immunoreactive 
microglia), sickness response (Godbout et al., 2005) and depressive 
behaviour (Godbout et al., 2008) has been reported. Ageing has also 
been shown to sensitize mice to the effects of E. Coli (Barrientos 
et al., 2006) and the HIV envelope protein, gp120 (Abraham et al., 
2008); in both cases, behavioural effects were greater and more per-
sistent in aged, compared with young, animals and the importance 
of IL-1β has been identiﬁ  ed by the ﬁ  nding that the effect of E. coli 
infection was inhibited by IL-1ra (Frank et al., 2009).Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  6 | 5
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aged rats to sustain LTP since intracerebroventricular injection of 
fractalkine attenuated both the age-related increase in microglial 
activation and the deﬁ  cit in LTP (Lyons et al., 2009a).
A parallel situation occurs with CD200, in the sense that receptor 
expression is conﬁ  ned to cells of the myeloid lineage and therefore 
expressed in the brain only on microglia, while the ligand is widely 
expressed and found on neurons as well as numerous other cells 
(Barclay et al., 2002; Lyons et al., 2007a). Interaction of CD200 with 
its receptor plays a signiﬁ  cant role in maintaining microglia in a 
quiescent state. Thus data from in vitro experiments have shown 
that addition of neurons to LPS- or Aβ-treated microglia decreases 
cell surface expression of activation markers and also decreases 
release of proinﬂ  ammatory cytokines (Lyons et al., 2007a,b); these 
changes are blocked by an anti-CD200 antibody. We have recently 
shown that CD200Fc exerts a similar effect (Cox et al., 2009). Data 
from in vivo experiments have similarly identiﬁ  ed the importance 
of CD200 ligand-receptor interaction in maintenance of microglia 
in a quiescent state; decreased CD200 expression, for example in 
aged rats and Aβ-treated rats is accompanied by increased micro-
glial activation (Lyons et al., 2007a, 2009b) and we have recently 
shown that both the LPS- and age-related deﬁ  cit in LTP are attenu-
ated by intracerebroventricular injection of CD200Fc (Cox et al., 
2009). Consistent with these ﬁ  ndings, CD200−/− mice express an 
inﬂ  ammatory phenotype, and we have recently established that glial 
cells prepared from CD200−/− mice exhibit an exaggerated response 
to LPS with increased production and release of IL-1β, IL-6 and 
TNFα(Cox and Lynch, 2009). Analysis of LTP in hippocampal slices 
prepared from these mice revealed, ﬁ  rst, that LTP was decreased 
compared with that obtained in slices from wild-type mice and, 
second, that LPS exerted a greater effect on LTP in slices prepared 
from CD200−/−, compared with wild-type, mice.
HOW CAN THE AGE-RELATED INFLAMMATORY CHANGES BE 
MODULATED? DOES THIS IMPACT ON FUNCTION?
The data described above have indicated that the deﬁ  cit in LTP 
induced by LPS can be rescued by CD200Fc and, at least in this 
instance, the underlying action is to ameliorate the LPS-induced 
microglial activation by increasing CD200 receptor activation. 
Among the factors which increases expression of CD200 is IL-4 
(Lyons et al., 2007a, 2009b) and, consistently, IL-4 has been shown 
to ameliorate the age-related impairment in LTP (Nolan et al., 2005) 
while it attenuates the Aβ-induced decrease in LTP (Lyons et al., 
2007b) and reverses the associated decrease in CD200 (Lyons et al., 
2009b). The negative impact of microglial activation on synaptic 
plasticity has been highlighted by the ﬁ  nding that treatment of aged 
rats with the inhibitor of microglial activation, minocycline, orally 
for 10 days partially attenuates the decrease in LTP (Grifﬁ  n et al., 
2006) while treatment of 12-month-old mice which overexpress 
APP improved spatial learning (Fan et al., 2007).
A number of studies have provided further similar evidence 
indicating that agents which inhibit microglial activation have the 
capability of attenuating the deﬁ  cits in LTP which occur in aged 
rats and/or in Aβ and LPS-treated rats; these include the statin, 
atorvastatin (Clarke et al., 2007, 2008), a peptide which activates 
ﬁ  broblast growth factor receptor, FG loop, (Downer et al., 2010), 
rosiglitazone (Loane et al., 2009), and EPA (Minogue et al., 2007). 
In each of these situations, the evidence indicates that the deﬁ  -
cit in LTP is accompanied by evidence of microglial activation 
and that treatment with the agent decreases microglial activation 
and restores LTP. Some groups have also used this approach to 
consolidate the coupling of microglial activation and deﬁ  cits in 
behavioural tasks; for example it has been shown that antioxi-
dants, including foods with antioxidant properties attenuate the 
age-related deﬁ  cits in spatial learning (Youdim and Joseph, 2001) 
and also reduce microglial activation (Lau et al., 2007). Similarly 
n-3 polyunsaturated fatty acids, which have anti-inﬂ  ammatory 
effects (Lynch et al., 2007) attenuate age-related deﬁ  cits in spatial 
learning (Lim et al., 2005) and beneﬁ  cial effects of curcumin have 
also been described (Frautschy et al., 2001). These data are useful 
in establishing parallels between microglial activation and synaptic 
plasticity with the signiﬁ  cant limitation that they do not imply a 
causative interaction. It is important to recognize an additional 
limitation, i.e. that these data are based on a limited assessment of 
microglial activation, for example expression of cell surface markers 
of activation, or presumed microglial activation like inﬂ  ammatory 
cytokine production. Accordingly while the circumstantial evidence 
suggesting the importance of microglial activation in inducing the 
age-related deﬁ  cit in synaptic function is overwhelming, a more 
precise understanding of what is meant by the term ‘microglial 
activation’ is necessary, and a scientiﬁ  c approach which is more 
sophisticated than provision of correlational data is required, before 
there can be unequivocal acceptance of the causal relationship.
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